Endotoxin-induced disseminated intravascular coagulation in rabbits: Effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 1, 1998, Pages 77-83

  Hermida, José ^a   Montes, Ramón ^a   Páramo, José Antonio ^a   Rocha, Eduardo ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031951289     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90080-4     Document Type: Article

References (45)

1. Bick RL. Disseminated intravascular coagulation. Hematol Oncol Clin North Am 1992;6:1259-85.
2. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980;68:344-55.
3. Warr TA, Mohan Rao LV, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990;75:1481-9.
4. Fenton JW II. Thrombin. Ann NY Acad Sci 1986;485:5-15.
5. Malar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982;59:1067-72.
6. Robboy SJ, Major MC, Colman RW, Minna JD. Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases. Hum Pathol 1972;3:327-43.
7. Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985;75:818-24.
8. Crutchley DJ, Conanan LB. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J Biol Chem 1986;261:154-9.
9. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects,. N Engl J Med 1989;320:1165-72.
10. Paramo JA. Fernandez FJ, Rocha E. Plasminogen activator inhibitor activity in bacterial infection. Thromb Haemost 1988;59:451-4.
11. Paramo JA, Perez JL, Serrano M, Rocha E. Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis. Thromb Haemost 1990;64:3-6.
12. Gomez C, Paramo JA, Colucci M, Rocha E. Effect of heparin and/or antithrombin III on the generation of endotoxininduced plasminogen activator inhibitor. Thromb Haemost 1989;62:694-8.
13. Paloma MJ, Paramo JA, Rocha E. Effects of DDAVP on endotoxin-induced intravascular coagulation in rabbits. Thromb Haemost 1992;68:306-9.
14. Paloma MJ, Paramo JA, Rocha E. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase on PAI generation, fibrin deposits, and mortality. Thromb Haemost 1995;74:1578-82.
15. Markward F. Hirudin and derivatives as anticoagulant agents. Thromb Haemost 1991;66:141-52.
16. Weitz JI, Hudoba M, Massel D, et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385-91.
17. Biemond BJ, Levi M, Ten Cate H, et al. Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci Colch 1995;88:587-94.
18. Klement P, Smith S, Hirsh J, Weitz J. Hirudin, but not heparin, accelerates physiologic fibrinolysis in a rabbit chronic venous thrombosis model [abstract]. Thromb Haemost 1995;73:2118.
19. Biemond BJ, Friederich PW, Levi M, et al. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis. Circulation 1996; 93:153-60.
20. Chorda C, Paramo JA, Rocha E. Comparison of the effects of unfractionated heparin, low molecular weight heparin and hirudin (Revasc™) on the fibrinolytic potential of cultured human umbilical vein endothelial cells. Fibrinolysis 1996;10: 43-8.
21. Weitz JI, Califf RM, Ginsberg JS, et al. New antithrombotics. Chest 1995;108(suppl 4):471S-85S.
22. Ishikawa A, Hafter R, Seemuller U, et al. The effect of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC). Thromb Res 1980;19:351-8.
23. Hoffmann H, Siebeck M, Spannagl M, et al. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. Am Rev Respir Dis 1990;142:782-8.
24. Dickneite G, Czech J, Keuper H. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin. Circ Shock 1994; 42:183-9.
25. Dickneite G, Czech J. Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis. Thromb Haemost 1994;71:768-72.
26. Zawilska K, Zozulinska M, Turowiecka Z, et al. The effects of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular cephalothin (DIC) in rabbits. Thromb Res 1993;69:315-20.
27. Clause A. Gerinnungs physiologische schnell methode zur bestimmung des fibrinogens. Acta Haematol 1957;17:237.28.
28. Andersson EN, Menschik M, van Voorhuizen H. New chromogenic ATIII activity kit which is sensitive to heparin cofactor II and designed for use on automated instruments [abstract]. Thromb Haemost 1991;65:766.
29. Vinazzer H, Pangraz U. Protein C: comparison of different assays in normal and abnormal plasma samples. Thromb Res 1987;46:1-8.
30. Krishnamurti C, Barr CF, Hasset MA, et al. Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits. Blood 1987;69:798-803.
31. Verheijen JH, Mullaat E, Chang GTG, et al. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982;48:266-9.
32. Paramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor. Relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost 1985;54: 713-6.
33. Taylor FB Jr, Chang A, Esmon CT, et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987;79:918-25.
34. Fijnvandraat K, Derkx B, Peters M, et al. Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality. Thromb Haemost 1995;73:15-20.
35. Esmon CT, Taylor FB Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991;66:160-5.
36. Krishnamurti C, Bolan C, Colletin CA, et al. Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombin. Blood 1993;82: 3631-6.
37. Krishnamurti C, Keyt B, Maglasang P, Alving BM. PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activity. Blood 1996;87:16-9.
38. Van Hinsberg VWM, Sprengers DE, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 1987;57:148-53.
39. Gelehrter TD, Szyncer-Laszuk R. Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells. J Clin Invest 1986;77:165-9.
40. Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J Lab Clin Med 1987;109:97-104.
41. Breddin HK, Markwardt F. Clinical experience with hirudin in disseminated intravascular coagulation [abstract]. Thromb Haemost 1993;69:1299.
42. Saito M, Asakura H, Jokaji H, et al. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with hematological malignancy. Blood Coagul Fibrinolysis 1995;6:60-4.
43. Laemmle B, Tran TH, Ritz R, Duckert F. Plasma pre-kallikrein, factor XII, antithrombin III, Cl-inhibitor, and α2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol 1984;82:396-404.
44. Lauritsen B. Faber V, Brock A, et al. Disseminated intravascular coagulation, antithrombin III, and complement in meningococcal infections. Acta Med Scand 1981;209:221-7.
45. Bick RL, Bick MP, Fekete LF. Antithrombin III patterns in disseminated intravascular coagulation. Am J Clin Pathol 1980;73:577-83.